ESA Innovation Exchange Initiative: When Space Meets Health

Zurück zur Übersicht

Sie befinden sich hier:

Ausschließlich für Fachpublikum

ESA-Charité in-kind partnership


Programme (draft)

09:30 – 10:00 Registration
10:00 – 10:05 Welcome Address
10:05 – 10:15 Introduction to ESA Space Exploration programme and ESA Innovation Exchange project
10:15 – 10:25 Presentation of programme, objectives and ESA life sciences / MAPs programmes
10:25 – 10:30 Opening Remarks
10:30 – 10:40 Keynote speech: “Space and global health, projects and perspectives
10:40 – 10:50 Presentation on technology roadmaps and identified knowledge gaps for space exploration
10:50 – 11:00 Presentation on ESA programmes supporting health-related technology R&D and applications/services
11:00 – 11:15 Coffee break
11:15 – 11:25 Presentation on ESA Technology Transfer programme and R&D opportunities
11:25 – 11:55 Keynote presentations on success cases of synergies space/terrestrial R&D
11:55 – 12:00 Plenary Q&A
12:00 – 13:00 Splinter sessions on each of the 5 themes (moderated by Chair + 1-2 non-space industry and/or science experts(s) + 1 ESA Organisation Committee member, and based on a set of questions and active participation of group members) – Part I
13:00 – 14:00 Lunch
14:00 – 15:30 Splinter sessions on each of the 5 themes (moderated by Chair + 1-2 non-space industry and/or science experts(s) + 1 ESA Organisation Committee Member, and based on a set of questions and active participation of group members) – Part II
15:30 – 15:45 Coffee break
15:45 – 15:55 Presentation on ESA procurement procedures / legal framework relevant for P.P.P.
15:55 – 16:45 Plenary session – Feedback from 5 thematic splinter groups (Chairs of Splinter Sessions reporting)
16:45 – 17:00 General conclusions – Next steps


Registration deadline: Monday, 24 October 2016




In 2015, the European Space Agency (ESA) published its Space Exploration Strategy which is based on 4 strategic goals (science, economics, global cooperation, and inspiration) and which opens-up new opportunities for delivering benefits to society.

To create and capitalise on those opportunities, ESA is taking a more proactive role in fostering cross-synergies between space and terrestrial R&D, and has initiated the ESA Open Innovation Exchange project.

Exchange Objectives

The ESA Innovation Exchange: When Space Meets Health aims to:

  • Increase awareness among stakeholders from the institutional and private healthcare sector about the ESA strategy, technology roadmaps and identified knowledge gaps for space exploration, and the ESA life sciences, technology R&D and applications/services programmes.

  • Initiate a dialogue between ESA and stakeholders from the institutional and private healthcare sector on scientific research and technologies of common interest in order to identify potential new space/non-space cross synergies.

  • Identify the potential application of space technology in the healthcare sector (the SPIN-OUT potential) and the SPIN-IN potential of the healthcare sector R&D for space exploration.
        Incentivize stakeholders from the institutional and private healthcare sector to engage with ESA.

  • Explore opportunities for potential partnerships with the institutional and private healthcare sector for mutually beneficial R&D and applications/services purposes.

  • Strengthen European collaboration and excellence in science and technology R&D.


The event will include 5 thematic splinter group discussions on a broad range of topics that will form the basis for eliciting ideas for potential partnerships moving forward, and for reinforcing cross-synergies space/terrestrial healthcare R&D and the transfer of medical know-how and technologies for the benefit of both space exploration and society on Earth.

Splinter 1 – Remote and autonomous healthcare monitoring and intervention

  • Focus on – Practising and managing healthcare as well as facilitating its application by means of electronic processes and communication.
  • Topics (examples) – Remote medical assistance, humanitarian crisis management, intervention, and training (e.g. telemedicine, tele-assisted surgery and tele-education).

Splinter 2 – Advanced medical diagnostics and therapies, imaging, point-of-care and e-health technologies

  • Focus on – New advanced tools for the analysis and protection of the individual’s health status and for the treatment of specific pathophysiological conditions.
  • Topics (examples) – R&D of new techniques/devices for faster identification of specific biomarkers, symptoms/countermeasures in both the laboratories and in-situ.

Splinter 3 – Health issues associated with ageing and sedentary population

  • Focus on – Health issues associated with an increasing proportion of elderly people in the population and obesity.
  • Topics (examples) – Present and future analysis of the underlying process of health issues associated with ageing and inactivity, medical assistance and mitigation methodologies.

Splinter 4 – Genetics and personalised medicine

  • Focus on – Advancements in healthcare management by means of analytical and interventional tools involving genetic mechanisms and related modifications (i.e. epigenetics) and interactions with the -omics (i.e. proteomics and metabolomics).
  • Topics (examples) – Personalised medicine via the design and generation of ad hoc health screening tests, pharmaceutical compounds and related new biotechnological techniques and devices to achieve them.

Splinter 5 – Environmental risk assessment models, surveillance, protection and countermeasures

  •  Focus on – Management of the risks posed to health by different environmental hazards such as radiation, toxic pollutants and contaminants.
  • Topics (examples) – Improved monitoring, prevention, mitigation and solutions to health protection issues related to environmental hazards with special emphasis on the radiation topic (e.g. radiation shielding/countermeasures and radiation therapy), epidemiology, simultaneous exposure to multiple environmental stressors.





ESA organising committee

J. Hatton – ESA/ESTEC
S. Ijsselstein – ESA/ESTEC

A. Daniels – ESA/ESTEC
V. La Regina – ESA/ESTEC
A. Runge – ESA/ESTEC
U. Straube – ESA/EAC
L. Surdo – ESA/ESTEC

Scientific committee

M. Durante - Director TIFPA-INFN, University of Trento, Italy
N. Pattyn - Medical Doctor, Royal Military Academy of Belgium, Belgium
C. Pucillo - University of Udine, Italy

Industrial committee

M. Bansmann - Chief Consultant, Institut für Diagnostische und Interventionelle Radiologie, Kardio MR/CT Köln/Bonn, Germany
D. Schneemann - Innovation Consultancy & Design, Verhaert New Products & Services, ESIC – European Space Innovation Centre, The Netherlands
B. Rivollet - CEO, Tech2Market, France
S. Waes - Consultant Innovation & Design and ESA Prime Broker – Technology Transfer Program, Verhaert New Products & Services, Belgium


8 November 2016


Noordwijk, NL

ESA European Space Research and Technology Centre (ESA/ESTEC)
Keplerlaan 1, 2200 AG Noordwijk, The Netherlands

Request for Registration
After posting your Request for Registration, you will receive an automatic delivery confirmation. In order to enable active participation and fruitful exchange with everyone, event attendance has been limited. The event’s organising committee will process your request, and you will receive an acceptance response within 5 working days. The participation to the event is free of charge.

Deadline: Monday, 24 October 2016

More on:



Registration and more information:

Center for Space Medicine and Extreme Environments Berlin


Strategic Planning and Outreach Office
Human Spaceflight and Robotic Exploration

Keplerlaan 1  –  2200AG Noordwijk  –  The Netherlands[at]

Zurück zur Übersicht